Your Complete Policy Management Partner

Everything your healthcare organization needs to confidently maintain accreditation compliance.

Robust document control and workflow management software solution

Simplify & automate policy access, review and approval across your organization

Web-based library of more than 18,000 customizable policy documents

Instantly access up-to-date policies, procedures & forms authored by MCN experts

Automated regulatory notification system of daily email or mobile alerts

Keep current with regulatory changes from more than a dozen federal regulatory bodies, including TJC & NIAHO

What Our Customers are Saying

MCN Healthcare has been indispensable to our accreditation compliance efforts. With Policy Manager, Policy Library and StayAlert!, we have peace of mind that our policies will always be up-to-date and easy to locate.

Beverly McKenzie, Compliance Programs Director, IASIS Healthcare

MCN Foundation Logo See how MCN gives back to the global healthcare community through the MCN Foundation

Helpful MCN Healthcare Resources

MCN Healthcare: StayAlert! - Immediate Regulatory Updates Icon

StayAlert! Headlines

May 15 2015
FDA Issues Drug Safety Communication for certain Type 2 Diabetes Medications

The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis.  The FDA is continuing to investigate this safety issue and will determine whether changes are needed in the prescribing information for this class of drugs, called sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Patients taking these medications should be advised to pay close attention for any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness. Diabetes medicines should not be stopped or changed without prescriber consultation.

Health care professionals should evaluate for the presence of acidosis, including ketoacidosis, in patients experiencing these signs or symptoms; discontinue SGLT2 inhibitors if acidosis is confirmed; and take appropriate measures to correct the acidosis and monitor sugar levels.

For additional information please follow the link below.

Read more »
May 15 2015
Joint Commission Field Review - Diagnostic Imaging Standards Changes for Technologists

The Joint Commission (TJC) is proposing standards changes related to Diagnostic Imaging requirements for their Ambulatory Care, Critical Access Hospital, and Hospital accreditation programs.

As a part of the standards development process, TJC is now seeking input on proposed new and revised diagnostic imaging requirements that address minimum qualifications for technologists who perform diagnostic CT exams in the Ambulatory Care, Critical Access Hospital, and Hospital programs. 

The proposed standards are presented with in a series of survey questions, the link to the online survey is provided below.  Comments will be collected through June 25, 2015.

Read more »
May 14 2015
LifeCare PCA3 and PCA5 Infusion Pump Systems by Hospira: FDA Safety Communication - Security Vulnerabilities

As StayAlert reported on May 7, 2015, the Food and Drug Administration (FDA) and Hospira have become aware of security vulnerabilities in Hospira's LifeCare PCA3 and PCA5 Infusion Pump Systems.  An independent researcher has released information about these vulnerabilities, including software codes, which, if exploited, could allow an unauthorized user to interfere with the pump's functioning. An unauthorized user with malicious intent could access the pump remotely and modify the dosage it delivers, which could lead to over- or under-infusion of critical therapies. The FDA is not aware of any patient adverse events or unauthorized device access related to these vulnerabilities.

The FDA is actively investigating the situation based on current information and close engagement with Hospira and the Department of Homeland Security. As new information becomes available about patient risks and any additional steps users should take to secure these devices, the FDA will communicate publicly.

The Hospira LifeCare PCA3 and PCA5 Infusion Pump Systems are computerized infusion pumps designed for the continuous delivery of anesthetic or therapeutic drugs. These systems can be programmed remotely through a health care facility's Ethernet or wireless network.

The FDA has issued a Drug Safety Communication with the following recommendations for Health Care Facilities:

  • Follow the recommendations from the Industrial Control Systems Cyber Emergency Response Team (ICS-CERT) of the U.S.Department of Homeland in the May 13, 2015 Advisory Hospira LifeCare PCA Infusion System Vulnerabilities (Update A).
  • Perform a risk assessment by examining the specific clinical use of the Hospira LifeCare PCA Infusion Pump System in your organization's environment to identify any potential impacts of the identified vulnerabilities.
  • Look for and follow risk mitigation strategies outlined in an upcoming letter from Hospira to its customers. Customers can access the instructions and other risk mitigation measures via Hospira's Advanced Knowledge Center.
  • Follow the good cybersecurity hygiene practices outlined in the FDA Safety Communication Cybersecurity for Medical Devices and Hospital Networks, posted in June 2013.
  • Refer to the FDA Safety Alert for detailed recommendations including a link to the ICS-CERT.

Read the MedWatch safety alert, including links to the FDA Safety Communication at  the link below.

Read more »
MCN Healthcare: Policy Library - Customizable Policy Documents Icon

Featured Policy Library Manuals

Policy Library Manuals: Ambulatory Surgical Center and Outpatient Surgery Department Policy and Procedure Manual Icon
Ambulatory Surgical Center and Outpatient Surgery Department Policy and Procedure Manual

MCN's NEW Ambulatory Surgical Center/Outpatient Surgery Department Policy and Procedure Manual is cross referenced to TJC standards, AAAHC standards and CMS regulations. Policies and procedures meet AORN and CDC recommendations and guidelines. This comprehensive reference guide has over 290 policies and procedures that are ready to customize to your organization. See also the Administrative Manual for Ambulatory Care Facilities and the Ambulatory Services EOC Manual.

Read more »
Policy Library Manuals: Home Health Policy and Procedure Manual Icon
Home Health Policy and Procedure Manual

MCN Healthcare’s Home Health Policy and Procedure Manual provides over 400 policies and procedures addressing administration, emergency management, human resources, medical records, infection control, safety and security, equipment management, medication management, performance improvement, patient rights and responsibilities, waived testing as well as patient care. The Home Health Policy and Procedure Manual is cross referenced to CMS regulations, TJC, ACHC, and CHAP standards.

Read more »
Policy Library Manuals: Medical Office Policy and Procedure Manual Icon
Medical Office Policy and Procedure Manual

The Medical Office Policy and Procedure Manual is cross referenced to Joint Commission standards for Ambulatory Care and Primary Care Medical Homes and NCQA standards for Patient Centered Medical Homes. This manual includes policies that meet OSHA requirements for safety and infection control, Human Resources policies and Medical Office Compliance Plan and much more!

Read more »